First Bundibugyo Ebola Diagnostic Test Receives WHO Emergency Use Listing
The newly listed test detects Bundibugyo virus by identifying its genetic material in blood samples, enabling rapid and accurate confirmation of infection.
The newly listed test detects Bundibugyo virus by identifying its genetic material in blood samples, enabling rapid and accurate confirmation of infection.
Patients and healthcare providers are advised not to use any DARZALEX products bearing batch numbers MYS7381 or STV1K01.
WHO is encouraging all countries to begin newborn screening with priority conditions and gradually expand as healthcare capacity grows.